Endometrial cancer begins in the inner glandular lining of the uterus (the endometrium) and makes up about 95% of cases of cancer in the uterus. It is the most common gynecological cancer in Canada, with 8,600 Canadians diagnosed in 2024, according to IHE’s Case Study on Endometrial Cancer in Canada.
Before deciding on a treatment plan, a pathologist looks at the cancer tissue under a microscope to understand its type, how aggressive it is, and how far it has spread. They also do molecular tests, like checking for certain proteins or changes in the DNA. This information helps doctors understand:
- How likely surgery alone will be enough to treat the cancer
- Whether additional treatments are needed
- The risk of the cancer spreading or coming back
This information was developed in consultation with leading Canadian gynecologic oncologists and reviewed by Alicia Tone, PhD.
Does endometrial cancer spread?
Staging
Endometrial cancer might spread. Traditional surgical staging is a procedure doctors use to find out how far endometrial cancer has spread.
Surgical staging usually includes removing the uterus, fallopian tubes, and ovaries, checking nearby lymph nodes, and taking small tissue samples (biopsies). After surgery, a pathologist examines the tissue to determine the stage of the cancer, which ranges from stage I (cancer is only in the uterus) to stage IV (cancer has spread to other parts of the body). Sub-stages give more detail about how far the cancer has spread, your team may discuss this with your further.
The Stages of Endometrial Cancer
- Stage I – Cancer is only found in the uterus. Sub-stages (IA, IB) describe how deeply it has grown into the wall of the uterus.
- Stage II – Cancer is still in the uterus but has also spread to the cervix (the lower part of the uterus).
- Stage III – The cancer has grown beyond the inside of the uterus and cervix but is still within the pelvic area or in lymph nodes in the pelvis or abdominal area. It may have reached the outer surface of the uterus, the ovaries, fallopian tubes, vagina, or nearby lymph nodes.
- Stage IV – The cancer has moved into nearby organs like the bladder or bowel, or to distant organs such as the lungs or liver.
What are the types of endometrial cancer?
Histotype, Grade and Molecular Classification
Histotype
Histotype describes the type of endometrial cancer based on how the tumor looks under a microscope.
- Endometrioid: This is the most common type of endometrial cancers (over 70% of cases) and can be grade 1, 2 or 3.
- Other types: Serous, clear cell, carcinosarcoma, dedifferentiated/undifferentiated, mesonephric-like, and gastric-type cancers. These are all less common and are usually high grade (grade 3).
Grade
Grading describes how crowded the endometrial glands are, and how worrisome they look under a microscope.
The more the cancer cells look like a normal cell, the more they will behave like a normal cell and are likely to grow slowly.
The grades of endometrial cancer
- Grade 1 (low grade): Cells look fairly normal and are only slightly crowded. These cancers usually grow slowly and have a lower risk of spreading.
- Grade 2 (intermediate grade): Cells are more crowded and look a bit more abnormal, but often still behave like low-grade tumors.
- Grade 3 (high grade): Cells look very abnormal and look more like sheets of tumour. These cancers are more likely to spread or come back after treatment.
Molecular classification
Along with the stage, grade, and histotype, endometrial cancers can also be grouped into molecular subtypes.
Knowing the subtype helps doctors predict how likely the cancer is to come back (known as recurrence) and can help them choose the most effective treatment. The four molecular subtypes are:
These cancers have specific mutations in a gene called POLE. They often look aggressive under the microscope but have an excellent prognosis and can often be spared any additional treatments beyond surgery (like chemotherapy or radiation).
In these cancers, the body’s “DNA repair system” doesn’t work properly. That means cancer cells can’t fix mistakes in their DNA, which helps the cancer grow. They may be linked to an inherited condition called Lynch syndrome. MMR-deficient cancers have a moderate chance of coming back (recurrence) — higher than POLE cancers but lower than p53-abnormal cancers (described below). Patients with MMRd endometrial cancers can respond well to certain treatments, such as immunotherapy.
These cancers have a change in p53 protein expression or have changes in a gene called TP53, which normally helps control how cells grow and divide. When this gene isn’t working properly, the cancer can grow and spread more quickly. Because of this, p53-abnormal cancers are usually more aggressive and may require more extensive surgery and treatment.
These cancers don’t have any of the changes seen in the other groups — no POLE mutation, MMR deficiency, or p53 abnormality. They are considered to have a moderate (intermediate) risk of coming back, similar to MMR-deficient cancers. Doctors now also look at estrogen receptor (ER) levels, which can help show whether someone may need additional treatment. ER-positive (ER+) means the cancer cells have estrogen receptors and ER-negative (ER-) means the cancer cells do not have estrogen receptors.
How is endometrial cancer treated?
How endometrial cancer is treated, including the surgery performed, and therapies given after surgery, may vary between hospitals and doctors.
Overall treatment plans are based on:
- The stage of the cancer
- The grade of the cancer
- The histotype and/or molecular subtype of the cancer
- Your age and general health
- Your future fertility goals, if any
Surgery is often the main treatment, with other options like radiation, chemotherapy, hormone therapy, targeted therapies, or immunotherapies used in combination, depending on the specific characteristics of the cancer and the individual’s circumstances.
Surgery for endometrial cancer
Surgery is often the first step in treating most endometrial cancers. Surgical options can sometimes be adjusted based on age, health, and personal wishes:
- For some younger patients with precancer or early-stage cancer, the ovaries may be left in place to prevent early menopause. This can slightly increase the chance of the cancer returning.
- For people who still wish to have children, surgery may be postponed, and other treatments may be used first e.g., hormonal therapy (progesterone), to treat the cancer.
- If surgery isn’t safe because of other health conditions, treatments such as radiation or hormone treatment may be recommended instead.
Is Radiation Used to Treat Endometrial Cancer?
Radiation therapy may be used to treat endometrial cancer following surgery. It uses a very high localized dose of radiation to destroy cancer cells and damage the DNA of the cancer cells so that it can no longer divide and grow (this is a different approach to chemotherapy which destroys cancer cells throughout the body).
How is radiation given to treat endometrial cancer?
Radiation is given in two main ways:
- Internal radiation (brachytherapy): A small amount of radioactive material is placed inside the body, close to where the cancer is.
- External beam radiation therapy: A machine outside the body aims radiation at the tumor, similar to getting an X-ray.
Sometimes both types are used. In most of these cases, external beam radiation is given first, followed by brachytherapy.
The type of radiation – and the areas to be treated – will be based on stage (how far the cancer has spread) and grade (how the cancer cells look under a microscope).
What are the side effects of radiation treatment?
Side effects of radiation treatment may include:
- Fatigue
- Mild redness/skin sensitivities
- Loss of appetite
- Hair loss in the pelvic region
- Nausea and vomiting
- Diarrhea or constipation
- Gas
- Bladder problems (frequent urination, discomfort, bleeding)
- Treatment-induced menopause
- Vaginal irritation
- Low blood counts
- Sexual changes
These side effects will fade once radiation therapy ends.
Chemotherapy for Endometrial Cancer
Chemotherapy is often used as a treatment for endometrial cancer, most commonly given after surgery but sometimes can be given before surgery. Chemotherapy, sometimes referred to as systemic therapy refers to intravenous or oral administration of cancer treatment to the whole body (as compared to radiation therapy which is usually to a specific anatomic area). There are many different types of chemotherapy protocols for endometrial cancer.
When is chemotherapy used to treat endometrial cancer?
- Chemotherapy is used as a treatment for high stage or aggressive endometrial cancer, most commonly given after surgery.
- Chemotherapy given after surgery (‘adjuvant’), is used to destroy any remaining cancer cells and is often accompanied by radiation therapy.
- Chemotherapy given before surgery (‘neoadjuvant’), reduces the size of the tumour and treats any accompanying fluid (ascites), making it easier to remove the cancer during surgery or to treat with radiation.
Which chemotherapy drugs are used to treat endometrial cancer?
Chemotherapy to treat endometrial cancer typically includes a combination of two different chemotherapy drugs; carboplatin and paclitaxel. These are administered intravenously (IV) so that they can circulate through the bloodstream.
Other Treatments for endometrial cancer
Hormone therapy is used to treat some endometrial cancer. It is believed to be most effective for endometrial cancers belonging to the NSMP molecular subtype and that have strong estrogen receptor expression (ER positive). The most common hormone therapy consists of a progesterone, either given by mouth or in an intra-uterine device (IUD). It is given most commonly in these situations:
- For younger patients who wish to preserve fertility and keep their uterus
- For advanced cancer (stage III or IV)
- If the cancer has come back after treatment (recurrence)
- For people with early-stage cancer who cannot have surgery for health reasons
Immunotherapy and Targeted Therapy: These are newer types of treatments for endometrial cancer. Most of these treatments are intravenous but some are oral. They work by focusing on specific features of the cancer. Whether these treatments are recommended depends on the molecular classification of the cancer.
Is endometrial cancer curable?
Remission and recurrence
Endometrial cancer has a high-five year survival rate (more than 80%), but initial treatment can have more than one outcome:
This indicates that the treatment has been effective. A complete treatment response means there is no evidence of disease, as shown by normal imaging (such as CT scans) and physical exams. Remission can last for months or years, and some patients may never experience a recurrence after the first treatment.
This means that the cancer, or any remaining cancer tissue, is still present, often smaller than before treatment. Follow-up scans and tests show that it is not growing over time.
This means that the cancer is growing. If progression occurs during or shortly after treatment, the healthcare team may adjust the treatment plan. If progression occurs after a period of remission, it is referred to as a recurrence.
After treatment is completed, patients may experience feelings of insecurity, loneliness, and fear of recurrence. They may also feel a heightened sense of responsibility for their own health. For those experiencing worry or stress, there are resources and support services available to help.
What Happens After Endometrial Cancer Treatment?
Follow-up tests and treatments will vary once treatment is complete. Patients will have scheduled visits with their doctor to:
- monitor their response to treatment
- recognize and immediately deal with any treatment-related complications
- monitor for a recurrence of the cancer
The frequency of visits will vary according to a patient’s specific situation, although a general guideline is:
- year 1-2: every 3-5 months
- years 3-5: every 6 months
- years 5+: annually
What Happens If Endometrial Cancer Comes Back?
When cancer returns after a period of remission, it is considered a recurrence.
Patients with endometrial cancer can experience a recurrence or multiple recurrences. For those who have experienced a recurrence, it may be helpful to think of endometrial cancer as a chronic disease that will need to be managed.
Treatment options for recurrence may include:
- use of chemotherapy drugs
- use of other drugs like immunotherapy
- surgery
- radiation (if localized)
Some considerations regarding treatment of recurrence include:
- Length of time from the finish of the first treatment series to recurrence (also called progression-free survival).
- Patient factors- overall health, personal values and choices
- Consideration of side effects, such as neuropathy, also needs to be given to the choice of chemotherapy drugs.
- Availability of clinical trials may be an option to be explored.
- Availability and/or cost of treatments offered
- Surgery for recurrent endometrial cancer may be an option if it has been a long time since completing chemotherapy and the new disease is only in one (or limited) area.
Support and education
Being diagnosed with endometrial cancer, uterine sarcoma, or facing a recurrence can feel overwhelming – know that you are not alone. It’s natural to have many questions and emotions during this time.
Understanding the complex experiences women face when navigating their healthcare is what we do best. As someone facing endometrial cancer or uterine sarcoma, you are welcome in our community. Find resources, information, and opportunities to connect with others who understand what you’re going through.
OVdialogue is our peer support online forum
Accessible 24/7, OVdialogue connects you with others facing ovarian cancer and endometrial cancer so you can share your experience, find and provide support, and much more.
Chat one-on-one in our peer support program
Our peer-to-peer support program can relieve your worries, answer your questions and help you through your diagnosis. You’ll speak over the phone one-on-one with someone who truly gets what you’re going through.
Teal Teas, monthly drop-in virtual support groups
In a friendly and trusting environment, you’re able to share information, experiences and conversation with others on the call to learn from and support each other.
There are many shared experiences between the ovarian and uterine cancer communities – including the physical side effects of treatment and the emotional challenges that come with a cancer diagnosis. This means we can learn from and support one another in meaningful ways.
General Information on Uterine and Endometrial Cancer
- American Cancer Society (ACS). What Is Endometrial Cancer? Updated 2024.
https://www.cancer.org/cancer/types/endometrial-cancer.html - National Cancer Institute (NCI). Endometrial Cancer Treatment (PDQ®)–Patient Version.
https://www.cancer.gov/types/uterine/patient/endometrial-treatment-pdq - Cancer Research UK. Types of womb cancer.
https://www.cancerresearchuk.org/about-cancer/womb-cancer/types
Staging, Grading, and Types
- National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients: Uterine Cancer. 2024.
Available free with registration: https://www.nccn.org/patients - FIGO (International Federation of Gynecology and Obstetrics). Endometrial Cancer Staging Overview (Patient Information). https://www.figo.org
Molecular Classification and Personalized Treatment
- National Cancer Institute. Biomarker Testing for Cancer Treatment.
https://www.cancer.gov/about-cancer/treatment/types/precision-medicine/biomarker-testing-cancer-treatment - Foundation for Women’s Cancer (SGO Patient Resource). Understanding Molecular Subtypes of Endometrial Cancer.
https://foundationforwomenscancer.org
Importance of Pathology and Molecular Testing
- American Society of Clinical Oncology (ASCO). Understanding Your Pathology Report: Uterine (Endometrial) Cancer.
https://www.cancer.net - Society of Gynecologic Oncology (SGO). Endometrial Cancer Basics.
Treatment and Prognosis Based on Subtype
- National Cancer Institute. Immunotherapy for Endometrial Cancer.
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy - American Cancer Society. Treatment Options by Stage of Endometrial Cancer.
Treatment
- NCCN (National Comprehensive Cancer Network). NCCN Guidelines for Patients: Uterine Cancer (2024). https://www.nccn.org/patients
- American Cancer Society. Treatment Choices for Endometrial Cancer, by Stage.
https://www.cancer.org/cancer/types/endometrial-cancer/treating/by-stage.html - National Cancer Institute (NCI). Endometrial Cancer Treatment (PDQ®)–Patient Version.
Surgery as the Main Treatment
- American Cancer Society. Surgery for Endometrial Cancer.
- National Cancer Institute. Surgery to Treat Uterine Cancer.
- Society of Gynecologic Oncology (SGO). Understanding the Role of a Gynecologic Oncologist.
https://www.sgo.org/patients-caregivers
Types of Surgeries and What They Include
- Foundation for Women’s Cancer. Endometrial Cancer: Treatment Options.
- Cancer Research UK. Surgery for womb cancer.
- NCI. Treatment options overview explains total hysterectomy with bilateral salpingo-oophorectomy and lymph node assessment.
Fertility Preservation & Ovarian Conservation
- American Cancer Society. Fertility and Endometrial Cancer.
- NCI. Fertility-Sparing Treatment for Endometrial Cancer.
These references support the information about conservative management using hormone therapy (e.g., progestins) for people wishing to preserve fertility.
Adjuvant Therapy (After Surgery)
- NCCN Guidelines (Patient Version) – details when radiation, chemotherapy, or immunotherapy is recommended based on risk factors and molecular subtype.
- National Cancer Institute. Immunotherapy for Endometrial Cancer.
- American Cancer Society. Chemotherapy and Radiation Therapy for Endometrial Cancer.
Recovery After Surgery
- Cancer Research UK. Recovering from womb cancer surgery.
- American Cancer Society. What to Expect After Endometrial Cancer Surgery.
These sources confirm: - Typical recovery is 6–8 weeks.
- Many patients return home within 1–3 days if minimally invasive surgery is used.
- Common side effects and warning signs to monitor are consistent with your content.
When Additional Treatments May Be Needed
- NCCN and NCI both emphasize that postoperative treatments depend on pathology results (stage, grade, and molecular classification).
- SGO and ACS support that many early-stage cancers require no further treatment after surgery.
Radiation Therapy
Supports: types of radiation, how they work, side effects, and treatment planning
- American Cancer Society. Radiation Therapy for Endometrial Cancer.
https://www.cancer.org/cancer/types/endometrial-cancer/treating/radiation.html - National Cancer Institute. Radiation Therapy to Treat Cancer (Patient Guide).
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy - *NCCN Guidelines for Patients: Uterine Cancer (2024).
https://www.nccn.org/patients - Cancer Research UK. Radiotherapy for womb cancer.
https://www.cancerresearchuk.org
Chemotherapy
Supports: use of chemotherapy after or before surgery, combination regimens (carboplatin + paclitaxel), oral vs IV delivery
- American Cancer Society. Chemotherapy for Endometrial Cancer.
- National Cancer Institute. Endometrial Cancer Treatment (Patient Version).
- *NCCN Guidelines for Patients: Uterine Cancer.
Hormone Therapy
Supports: use in fertility preservation, advanced or recurrent cancers, and ER-positive molecular subtype
- National Cancer Institute. Hormone Therapy for Endometrial Cancer.
- American Cancer Society. Hormone Therapy for Endometrial Cancer.
- Foundation for Women’s Cancer. Fertility-Sparing Treatments in Endometrial Cancer.
Immunotherapy & Targeted Therapy
Supports: precision treatment based on molecular testing (MMRd, p53, etc.)
- National Cancer Institute. Immunotherapy for Endometrial Cancer.
- American Cancer Society. Targeted Drug Therapy and Immunotherapy for Endometrial Cancer.
- *NCCN Guidelines for Patients: Uterine Cancer.
- U.S. FDA Approvals. Pembrolizumab and Dostarlimab for MMR-deficient endometrial cancers.
Supports: classification, differences from endometrial cancer, gene fusions in ESS
- American Cancer Society. About Uterine Sarcoma.
https://www.cancer.org/cancer/types/uterine-sarcoma.html - National Cancer Institute. Uterine Sarcoma Treatment (Patient Version).
- Cancer Research UK. Types of womb sarcoma.
- *NCCN Guidelines for Patients: Uterine Neoplasms.
Remission, Recurrence & Follow-Up
Supports: definitions of remission, recurrence, emotional impact, follow-up intervals, chronic disease management
- National Cancer Institute. Life After Cancer Treatment.
https://www.cancer.gov/about-cancer/coping/survivorship - American Cancer Society. Living as an Endometrial Cancer Survivor.
- *NCCN Survivorship Guidelines for Patients.
- Cancer Research UK. Follow-up after womb cancer treatment.